EUVIMEDEUVIMED entdecken
Crossref

Retrospective Analysis of Metabolic Risk Factors in Patients with Endometrial Hyperplasia

Bushra Mustafa, Pragati Pragati, Bindu Arya

International Journal of Pharmaceutical Quality Assurance · 09.07.2026 · 16 (09)

DOI: 10.25258/ijpqa.16.9.95 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 09.07.2026. Verfasst von Bushra Mustafa und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endometrial hyperplasia (EH) is characterized by abnormal proliferation of endometrial glands, often driven by unopposed estrogen exposure, and serves as a precursor to endometrial carcinoma. Metabolic disturbances such as obesity, insulin resistance, and dyslipidemia may influence its development.

Aim

To evaluate the association between EH and metabolic risk factors among women presenting with abnormal uterine bleeding. Methodology: A retrospective record-based study was conducted on 80 women aged 30–65 years who presented with abnormal uterine bleeding at the Department of Obstetrics and Gynaecology, Nalanda Medical College and Hospital, Patna. Patient records were reviewed to obtain demographic, clinical, biochemical, and histopathological data. Metabolic parameters assessed included body mass index (BMI), waist-to-hip ratio, blood pressure, fasting blood glucose, and lipid profile. Endometrial evaluation was based on transvaginal ultrasonography findings and histopathological examination of endometrial biopsy specimens. Statistical analysis was performed using t-test, chi-square test, and logistic regression to determine the association between metabolic risk factors and EH.

Results

EH was significantly associated with older age (48.6 ± 7.5 vs. 45.2 ± 6.8 years, p = 0.03), higher BMI (27.4 ± 3.2 vs. 24.8 ± 2.9 kg/m², p = 0.01), waist-to-hip ratio, hypertension, hyperglycemia, and dyslipidemia (all p < 0.01). Histopathology revealed 25% simple and 25% atypical hyperplasia. Logistic regression identified BMI ≥25, waist-to-hip ratio ≥0.85, and dyslipidemia as strong independent predictors.

Conclusion

Metabolic dysfunction plays a pivotal role in EH. Early detection and management of” metabolic risk factors are essential to prevent progression to malignancy

Zitieren

APA

Mustafa, B., Pragati, P., & Arya, B. (2026). Retrospective Analysis of Metabolic Risk Factors in Patients with Endometrial Hyperplasia. International Journal of Pharmaceutical Quality Assurance, 16(09). https://doi.org/10.25258/ijpqa.16.9.95

Vancouver

Mustafa B, Pragati P, Arya B. Retrospective Analysis of Metabolic Risk Factors in Patients with Endometrial Hyperplasia. International Journal of Pharmaceutical Quality Assurance. 2026;16(09). doi:10.25258/ijpqa.16.9.95

BibTeX
@article{Mustafa2026,
  author = {Mustafa, Bushra and Pragati, Pragati and Arya, Bindu},
  title = {Retrospective Analysis of Metabolic Risk Factors in Patients with Endometrial Hyperplasia},
  journal = {International Journal of Pharmaceutical Quality Assurance},
  year = {2026},
  volume = {16},
  number = {09},
  doi = {10.25258/ijpqa.16.9.95}
}
Kostenlos starten →